Works matching IS 20050380 AND DT 2023 AND VI 34 AND IP 2

Results: 15

Levonorgestrel-releasing intrauterine system-based therapies for earlystage endometrial cancer: a systematic review and meta-analysis.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e36

By:

Hongyi Wei;
Ningning Pan;
Wen Zhang;
Guangwu Xiong;
Wenping Guo;
Zhe Dong;
Caihong Ma

Publication type:

Article

Low-grade endometrial stromal sarcoma with intravenous thrombus extension: a multidisciplinary surgical challenge.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e21

By:

Rafael Guijarro-Campillo, Alberto;
Segarra Vidal, Blanca;
Lago, Víctor;
Padilla-Iserte, Pablo;
Hernández Chinchilla, Josselyn Andrea;
Martín-González, Iván;
Domingo del Pozo, Santiago

Publication type:

Article

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e33

By:

Tan, David;
Noriko Fujiwara;
Keiichi Fujiwara;
Beale, Philip;
Jae-Weon Kim;
Ng, Joseph;
Se Ik Kim;
Evans, Alison;
Byoung-Gie Kim

Publication type:

Article

Risk factors for and delayed recognition of genitourinary fistula following radical hysterectomy for cervical cancer: a population-based analysis.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e20

By:

Cong Liang;
Ping Liu;
Shan Kang;
Weili Li;
Biliang Chen;
Mei Ji;
Chunlin Chen

Publication type:

Article

CircSMAD2 accelerates endometrial cancer cell proliferation and metastasis by regulating the miR-1277-5p/MFGE8 axis.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e19

By:

Yan Wu;
Fuhua Wang;
Jing Shi;
Xiangyun Guo;
Feng Li

Publication type:

Article

Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e51

By:

Jung-Yun Lee;
Yoo-Young Lee;
Jeong-Yeol Park;
Seung-Hyuk Shim;
Se Ik Kim;
Tae-Wook Kong;
Chul Kwon Lim;
Hyun Woong Cho;
Dong Hoon Suh

Publication type:

Article

Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e39

By:

Dong Hoon Suh;
Hyeong In Ha;
Yeon Jee Lee;
Jiwon Lim;
Young-Joo Won;
Myong Cheol Lim

Publication type:

Article

Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT).

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e37

By:

Yang Li;
Changkun Zhu;
Hongyu Xie;
Yaxia Chen;
Weiguo Lv;
Xing Xie;
Xinyu Wang

Publication type:

Article

Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e18

By:

Jin Hwa Hong;
Hyun Woong Cho;
Yung-Taek Ouh;
Jae Kwan Lee;
Yikyeong Chun

Publication type:

Article

Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e17

By:

Yong Jae Lee;
Young Shin Chung;
Jung-Yun Lee;
Eun Ji Nam;
Sang Wun Kim;
Young Tae Kim;
Sunghoon Kim

Publication type:

Article

Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e12

By:

Ran Chu;
Penglin Liu;
Jingying Chen;
Xiaodong Cheng;
Kezhen Li;
Yanci Che;
Jianliu Wang;
Li Li;
Xi Zhang;
Shu Yao;
Li Song;
Ying Zhao;
Changzhen Huang;
Ying Xue;
Xiyu Pan;
Junting Li;
Zhongshao Chen;
Jie Jiang;
Beihua Kong;
Kun Song

Publication type:

Article

Number of FoxP3+ regulatory T-cells are associated with recurrence in vulvar squamous cell carcinoma.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e16

By:

Arık, Deniz;
Benli, Tutku;
Telli, Elçin

Publication type:

Article

A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e15

By:

Micha, John P.;
Rettenmaier, Mark A.;
Bohart, Randy D.;
Goldstein, Bram H.

Publication type:

Article

Validation of HPV triage in cytology-based cervical cancer screening for ASC-US cases using Japanese data.

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e14

By:

Eiko Saitoh Aoki;
Kumiko Saika;
Kazushige Kiguchi;
Tohru Morisada;
Daisuke Aoki

Publication type:

Article

Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on the prognosis and quality of life for patients with IB2-IIA2 Cervical Cancer: trial protocol for a randomized controlled trial (C-PACC trial).

Published in:

Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e13

By:

Xinyu Qu;
Junjun Qiu;
Lili Jiang;
Xiaorong Qi;
Guonan Zhang;
Weiwei Feng;
Yudong Wang;
Yincheng Teng;
Xipeng Wang;
Xiaoqing Guo;
Keqin Hua

Publication type:

Article